Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report Jianyong WuYan SongJianghua Chen Review Article 16 September 2009 Pages: 1169 - 1174
A fenugreek seed extract selectively reduces spontaneous fat consumption in healthy volunteers Hugues ChevassusNathalie MolinierPierre Petit Clinical Trial 07 October 2009 Pages: 1175 - 1178
Uptake of anthracyclines in vitro and in vivo in acute myeloid leukemia cells in relation to apoptosis and clinical response Alex BogasonHasanuzzaman BhuiyanSigurd Vitols Pharmacodynamics 10 October 2009 Pages: 1179 - 1186
Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling Dechun JiangXiangrong BaiMarkus Müller Pharmacogenetics 16 September 2009 Pages: 1187 - 1193
Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease Reinhild Klein Pharmacokinetics and Disposition 30 July 2009 Pages: 1195 - 1201
Assessment of inter-individual variability in predicted phenytoin clearance Thomas M. PolasekSebastian PolakJohn O. Miners Pharmacokinetics and Disposition 01 August 2009 Pages: 1203 - 1210
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis Adedigbo A. FasanmadeOmoniyi J. AdedokunHonghui Zhou Pharmacokinetics and Disposition Open access 16 September 2009 Pages: 1211 - 1228
Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents Pål GjerdenLars SlørdalJørgen G. Bramness Pharmacoepidemiology and Prescription 31 July 2009 Pages: 1229 - 1235
Risk of digoxin intoxication caused by clarithromycin–digoxin interactions in heart failure patients: a population-based study Agnes L. F. ChanMeng-Ting WangFu-Hsiung Tsai Pharmacoepidemiology and Prescription 05 August 2009 Pages: 1237 - 1243
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease Maurits E. L. ArbouwKris L. L. MovigHenk-Jan Guchelaar Pharmacoepidemiology and Prescription Open access 08 August 2009 Pages: 1245 - 1251
Evidence of safety of chloral hydrate for prolonged sedation in PICU in a tertiary teaching hospital in southern Brazil Jacqueline Kohut MartinbianchoPaulo Roberto Antonacci CarvalhoLeila Beltrami Moreira Pharmacoepidemiology and Prescription 11 August 2009 Pages: 1253 - 1258
Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes Moumita SarkarGideon KorenAdrienne Einarson Pharmacoepidemiology and Prescription 26 August 2009 Pages: 1259 - 1264
Therapeutic efficacy of acenocoumarol in a warfarin-resistant patient with deep venous thrombosis: a case report Srecko MarusicNives Gojo-TomicNada Bozina Letter to the Editors 04 August 2009 Pages: 1265 - 1266
Individualised dosing of amikacin in neonates Catherine M. T. SherwinRoland S. BroadbentDavid M. Reith Letter to the Editors 05 August 2009 Pages: 1267 - 1268
Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal Alfredo BellonJohn H. Coverdale Letter to the Editors 05 August 2009 Pages: 1269 - 1270
Paroxetine may cause increase in carcinoebmryonic antigen (CEA) Mehmet Emin CeylanAhmet TurkcanUrun Ozer Letter to the Editors 18 August 2009 Pages: 1271 - 1271
